CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
暂无分享,去创建一个
T. Kodama | Teppei Yoshioka | M. Shigekawa | Ryoko Yamada | H. Hikita | R. Sakamori | T. Tatsumi | T. Takehara | Y. Matsuura | T. Fukuhara | A. Nishio | Takahiro Suda | Tadashi Kegasawa | Kunimaro Furuta | T. Suda | Minoru Shigekawa
[1] Y. Matsuura,et al. Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae , 2017, PLoS pathogens.
[2] 西尾 啓. CD14⁺ Monocyte-Derived Galectin-9 Induces Natural Killer Cell Cytotoxicity in Chronic Hepatitis C , 2017 .
[3] Y. Maehara,et al. Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity , 2017, Scientific Reports.
[4] N. Hiramatsu,et al. CD14+ monocyte‐derived galectin‐9 induces natural killer cell cytotoxicity in chronic hepatitis C , 2017, Hepatology.
[5] T. Tatsumi,et al. Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[6] J. Murray,et al. Direct‐acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs , 2015, Hepatology.
[7] B. Rehermann. Natural Killer Cells in Viral Hepatitis , 2015, Cellular and molecular gastroenterology and hepatology.
[8] L. Mishra,et al. CEACAM1 Long Cytoplasmic Domain Isoform is Associated with Invasion and Recurrence of Hepatocellular Carcinoma , 2014, Annals of Surgical Oncology.
[9] H. Dienemann,et al. Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II interferons , 2013, Respiratory Research.
[10] E. Wang,et al. The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment , 2013, Gut.
[11] J. Nattermann,et al. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis , 2012, Hepatology.
[12] Y. Maehara,et al. Expression of MicroRNA miR-122 Facilitates an Efficient Replication in Nonhepatic Cells upon Infection with Hepatitis C Virus , 2012, Journal of Virology.
[13] Jeon‐Han Park,et al. Cell-to-Cell Contact with Hepatitis C Virus-Infected Cells Reduces Functional Capacity of Natural Killer Cells , 2011, Journal of Virology.
[14] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[15] N. Kato,et al. Elimination of Hepatitis C Virus from Hepatocytes by a Selective Activation of Therapeutic Molecules , 2011, PloS one.
[16] Jessica A. Randall,et al. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high‐risk individuals and inhibits replication in vitro , 2010, Hepatology.
[17] Céline Hernandez,et al. Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines , 2010, PLoS pathogens.
[18] A. Little,et al. Association of NKG2A with treatment for chronic hepatitis C virus infection , 2010, Clinical and experimental immunology.
[19] Barbara Rehermann,et al. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. , 2009, The Journal of clinical investigation.
[20] P. Tien,et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. , 2008, Clinical immunology.
[21] N. Greenberg,et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. , 2008, Immunity.
[22] G. Feldmann,et al. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C , 2005, Gut.
[23] S. Gray-Owen,et al. CEACAM1: contact-dependent control of immunity , 2006, Nature Reviews Immunology.
[24] N. Hayashi,et al. Antiviral therapy for chronic hepatitis C: past, present, and future , 2005, Journal of Gastroenterology.
[25] N. Hayashi,et al. Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection1 , 2004, The Journal of Immunology.
[26] O. Mandelboim,et al. CD66a Interactions Between Human Melanoma and NK Cells: A Novel Class I MHC-Independent Inhibitory Mechanism of Cytotoxicity1 , 2002, The Journal of Immunology.
[27] S. Nuti,et al. Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.
[28] D. R. Taylor,et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.
[29] J. Silver,et al. Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .
[30] R. Paxton,et al. Differential Regulation of Carcinoembryonic Antigen and Biliary Glycoprotein by 7-Interferon 1 , 2006 .
[31] R. Paxton,et al. Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon. , 1993, Cancer research.